# BJDX (Bluejay Diagnostics, Inc.) - SEC EDGAR Financial Statements

> Bluejay Diagnostics, Inc. reported $9.37M in total assets and a net loss of $7.68M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/BJDX
- Markdown: https://convexityos.com/fundamentals/BJDX.md
- SEC CIK: 0001704287
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:10 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001704287&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$7.81M | Operating profit |
| Net Income | FY 2025 | -$7.68M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$6.55 | Split-adjusted |
| Free Cash Flow | FY 2025 | -$6.23M | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $7.38M | Total debt: $56K |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | -- | -- | -- | $249K | -- | -- |
| Cost of Revenue | -- | -- | -- | $200K | -- | -- |
| **Gross Profit** | -- | -- | -- | $49K | -- | -- |
| Research & Development | $3.05M | $3.47M | $5.71M | $4.15M | $1.15M | $527K |
| Selling, General & Admin | -- | $3.70M | $283K | $451K | $2.08M | $669K |
| Total Operating Expenses | $6.95M | $7.17M | $10.31M | $9.37M | $3.23M | $1.20M |
| **Operating Income** | -$6.95M | -$7.17M | -$10.31M | -$9.32M | -$3.23M | -$1.20M |
| **EBITDA** | -$6.88M | -$7.09M | -$9.66M | -$9.16M | -$3.08M | -$1.04M |
| Interest Income | $98K | $146K | $165K | $90K | -- | -- |
| Interest Expense | $839 | $823K | -- | -- | $6.4K | $59K |
| **Net Income** | -$6.85M | -$7.72M | -$9.95M | -$9.30M | -$3.49M | -$1.16M |
| Basic EPS | -$244.00 | -$7,308.00 | -$11,620,736.00 | -$94,412,800.00 | -$83,968,000.00 | -$75,776,000.00 |
| **Diluted EPS** | -$244.00 | -$7,308.00 | -$11,620,736.00 | -$94,412,800.00 | -$83,968,000.00 | -$75,776,000.00 |
| Basic Shares Outstanding | 28.1K | 2.9K | 1 | 0 | 0 | 0 |
| Diluted Shares Outstanding | 28.1K | 2.9K | 1 | 0 | 0 | 0 |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $1.12M | $1.44M | $812K | $586K | $786K | $890K | $785K | $554K |
| Selling, General & Admin | -- | -- | -- | -- | -- | -- | -- | $931K |
| Total Operating Expenses | $2.06M | $2.35M | $1.94M | $1.46M | $1.62M | $1.99M | $1.89M | $1.48M |
| **Operating Income** | -$2.06M | -$2.35M | -$1.94M | -$1.46M | -$1.62M | -$1.99M | -$1.89M | -$1.48M |
| **EBITDA** | -$2.00M | -$2.32M | -$1.91M | -$1.43M | -$1.61M | -$1.97M | -$1.87M | -$1.46M |
| Interest Income | $50K | $25K | $19K | $32K | $19K | $29K | $18K | $39K |
| Interest Expense | -- | -- | -- | -- | $200 | $222 | -- | -- |
| **Net Income** | -$2.01M | -$2.32M | -$1.92M | -$1.43M | -$1.60M | -$1.96M | -$1.86M | -$1.43M |
| Basic EPS | -$1.72 | -$17.92 | -$31.20 | -- | -$16.92 | -$90.24 | -$215.36 | -- |
| **Diluted EPS** | -$1.72 | -$17.92 | -$31.20 | -- | -$16.92 | -$90.24 | -$215.36 | -- |
| Basic Shares Outstanding | 1.2M | 130.0K | 61.5K | -- | 94.4K | 21.7K | 8.7K | -- |
| Diluted Shares Outstanding | 1.2M | 130.0K | 61.5K | -- | 94.4K | 21.7K | 8.7K | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $5.16M | $4.30M | $2.21M | $10.11M | $19.05M | $912K |
| **Cash & Short-Term Investments** | $5.16M | $4.30M | $2.21M | $10.11M | $19.05M | $912K |
| Inventory | -- | -- | -- | -- | -- | $85K |
| **Total Current Assets** | $5.46M | $4.90M | $3.22M | $11.79M | $20.66M | $1.06M |
| Property, Plant & Equipment, Net | $1.53M | $1.51M | $1.29M | $1.23M | $337K | $459K |
| Other Non-Current Assets | $7.9K | $35K | $29K | $35K | $21K | -- |
| **Total Non-Current Assets** | $1.66M | $1.76M | $1.65M | $1.73M | $358K | $459K |
| **Total Assets** | $7.12M | $6.66M | $4.87M | $13.52M | $21.02M | $1.52M |
| Accounts Payable | $214K | $145K | $491K | $636K | $296K | $375K |
| **Total Current Liabilities** | $1.12M | $810K | $1.77M | $1.64M | $637K | -- |
| Other Non-Current Liabilities | $4.5K | $8.6K | $12K | $16K | -- | -- |
| **Total Non-Current Liabilities** | $25K | $118K | $202K | $340K | $0 | -- |
| **Total Liabilities** | $1.14M | $928K | $1.97M | $1.98M | $637K | $1.85M |
| **Total Debt (incl. Leases)** | $130K | $236K | $334K | $513K | -- | -- |
| Common Stock | $15 | $14 | $16 | $101 | $2.0K | $315 |
| Retained Earnings | -$41.52M | -$34.67M | -$26.95M | -$17.00M | -$7.69M | -$4.21M |
| **Total Stockholders' Equity** | $5.98M | $5.73M | $2.89M | $11.54M | $20.38M | -$4.21M |
| Total Equity | $5.98M | $5.73M | $2.89M | $11.54M | $20.38M | -$4.21M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $7.38M | $9.60M | $3.68M | $5.16M | $3.08M | $4.44M | $3.12M | $4.30M |
| **Cash & Short-Term Investments** | $7.38M | $9.60M | $3.68M | $5.16M | $3.08M | $4.44M | $3.12M | $4.30M |
| **Total Current Assets** | $7.54M | $9.81M | $3.97M | $5.46M | $3.35M | $4.75M | $3.57M | $4.90M |
| Property, Plant & Equipment, Net | $1.78M | $1.64M | $1.53M | $1.53M | $1.39M | $1.48M | $1.50M | $1.51M |
| Other Non-Current Assets | $5.4K | $6.3K | $11K | $7.9K | $8.7K | $22K | $34K | $35K |
| **Total Non-Current Assets** | $1.83M | $1.72M | $1.63M | $1.66M | $1.54M | $1.65M | $1.71M | $1.76M |
| **Total Assets** | $9.37M | $11.53M | $5.60M | $7.12M | $4.89M | $6.40M | $5.28M | $6.66M |
| Accounts Payable | $446K | $674K | $220K | $214K | $161K | $109K | $520K | $145K |
| **Total Current Liabilities** | $1.93M | $2.12M | $1.41M | $1.12M | $1.15M | $1.04M | $1.32M | $810K |
| Other Non-Current Liabilities | $1.3K | $2.4K | $3.5K | $4.5K | $5.6K | $6.6K | $7.6K | $8.6K |
| **Total Non-Current Liabilities** | $1.3K | $2.4K | $3.5K | $25K | $49K | $72K | $95K | $118K |
| **Total Liabilities** | $1.93M | $2.12M | $1.42M | $1.14M | $1.20M | $1.11M | $1.41M | $928K |
| **Total Debt (incl. Leases)** | $56K | $81K | $105K | $130K | $153K | $177K | $200K | $236K |
| Common Stock | $112 | $198 | $103 | $15 | $164 | $149 | $55 | $14 |
| Retained Earnings | -$47.77M | -$45.76M | -$43.44M | -$41.52M | -$40.09M | -$38.49M | -$36.53M | -$34.67M |
| **Total Stockholders' Equity** | $7.44M | $9.41M | $4.18M | $5.98M | $3.69M | $5.29M | $3.87M | $5.73M |
| Total Equity | $7.44M | $9.41M | $4.18M | $5.98M | $3.69M | $5.29M | $3.87M | $5.73M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$6.85M | -$7.72M | -$9.95M | -$9.30M | -$3.49M | -$1.16M |
| Depreciation & Amortization | $74K | $76K | $649K | $157K | $146K | $157K |
| Stock-Based Compensation | $6 | $20K | $189K | $433K | $68K | $3.7K |
| Change in Receivables | -- | -- | -- | -- | -- | $645 |
| Change in Inventory | -- | -- | -- | -- | $85K | $39K |
| Change in Payables | $69K | -$346K | -$236K | $299K | -$79K | $346K |
| **Operating Cash Flow** | -$6.05M | -$7.82M | -$8.31M | -$7.74M | -$4.37M | -$509K |
| Capital Expenditure | -$174K | -$307K | -$704K | -$1.20M | -$24K | -- |
| **Free Cash Flow** | -$6.23M | -$8.13M | -$9.02M | -$8.94M | -$4.39M | -- |
| **Investing Cash Flow** | -$174K | -$307K | -$704K | -$1.20M | -$24K | -- |
| Common Stock Issued | $8.35M | $12.07M | $1.59M | -- | -- | -- |
| **Financing Cash Flow** | $7.09M | $10.22M | $1.11M | $8.1K | $22.53M | $1.33M |
| **Net Change in Cash** | $863K | $2.09M | -$7.91M | -$8.93M | $18.14M | $816K |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$2.01M | -$2.32M | -$1.92M | -$1.43M | -$1.60M | -$1.96M | -$1.86M | -$1.43M |
| Depreciation & Amortization | $62K | $28K | $28K | $27K | $11K | $18K | $18K | $20K |
| Stock-Based Compensation | $56K | -- | -- | $74 | $183 | -$1.6K | $1.3K | -$2.6K |
| Change in Payables | -$228K | $454K | $6.0K | $53K | $52K | -$411K | $374K | -$172K |
| **Operating Cash Flow** | -$2.00M | -$1.50M | -$1.59M | -$1.45M | -$1.36M | -$2.05M | -$1.18M | -$1.45M |
| Capital Expenditure | -$197K | -$143K | -$19K | -- | -- | -- | -- | -$1.1K |
| **Free Cash Flow** | -$2.20M | -$1.64M | -$1.61M | -- | -- | -- | -- | -$1.45M |
| **Investing Cash Flow** | -$196K | -$143K | -$15K | -- | -- | -- | -- | -$1.1K |
| Common Stock Issued | $0 | $8.50M | $125K | -- | -- | -- | -- | $0 |
| **Financing Cash Flow** | -$20K | $7.56M | $124K | $3.71M | -$1.0K | $3.38M | -$985 | -$1.3K |
| **Net Change in Cash** | -$2.22M | $5.91M | -$1.48M | $2.08M | -$1.36M | $1.33M | -$1.19M | -$1.45M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | -- | -- | -- | 19.6% | -- | -- |
| **Operating Margin** | -- | -- | -- | -3741.5% | -- | -- |
| **Net Profit Margin** | -- | -- | -- | -3733.1% | -- | -- |
| Return on Equity (ROE) | -114.6% | -134.7% | -343.8% | -80.6% | -17.1% | -- |
| Return on Assets (ROA) | -96.2% | -115.9% | -204.5% | -68.8% | -16.6% | -76.3% |
| Current Ratio | 4.88x | 6.05x | 1.82x | 7.19x | 32.43x | -- |
| Quick Ratio | 4.61x | 5.31x | 1.25x | 6.17x | 29.89x | -- |
| Debt to Equity | 0.02x | 0.04x | 0.12x | 0.04x | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -103.3% | -77.2% | -165.1% | -114.6% | -185.5% | -127.3% | -187.6% | -134.7% |
| Return on Assets (ROA) | -82.0% | -63.0% | -123.3% | -96.2% | -140.1% | -105.2% | -137.4% | -115.9% |
| Current Ratio | 3.91x | 4.64x | 2.81x | 4.88x | 2.92x | 4.56x | 2.71x | 6.05x |
| Quick Ratio | 3.83x | 4.53x | 2.61x | 4.61x | 2.68x | 4.27x | 2.37x | 5.31x |
| Debt to Equity | 0.01x | 0.01x | 0.03x | 0.02x | 0.04x | 0.03x | 0.05x | 0.04x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
